Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center’s experience

References

• World Health Organization. WHO Director‐General's opening remarks at the media briefing on COVID‐19, 2020 March 11 [cited 2020 Mar 11]. Available from: https://www.Who.int/dg/speeches/detail/whodirectorgeneral’sopeningremarksatthemediabriefingoncovid19-11.
   Google Scholar
• International Pharmaceutical Federation. Coronavirus SARS-CoV-2 outbreak: information and guidelines for pharmacists and the pharmacy work force. Vol. 12. IPF; 2020.
   Google Scholar
• Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis. 2020 Mar 12.
   Web of Science ®Google Scholar
• Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020 Mar;21(3):335–7. Epub 2020 Feb 14.
   PubMed Web of Science ®Google Scholar
• Kamboj M, Sepkowitz KA. Nosocomial infections in patients with cancer. Lancet Oncol. 2009;10(6):589–97.
   PubMed Web of Science ®Google Scholar
• Longbottom ER, Torrance HD, Owen HC, Fragkou PC, Hinds CJ, Pearse RM, et al. Features of postoperative immune suppression are reversible with interferon gamma and independent of interleukin-6 pathways. Ann Surg. 2016; 264:370–7.
   PubMed Web of Science ®Google Scholar
• Sica A, Massarotti M. Myeloid suppressor cells in cancer and autoimmunity. J Autoimmun. 2017; 85:117–22.
   PubMed Web of Science ®Google Scholar
• Yu J, Ouyang W, Chua MLK, Xie C. SARS‐CoV‐2 transmission in cancer patients of a tertiary hospital in Wuhan. JAMA Oncol. 2020 Mar 25;6(7):1108..
   PubMed Web of Science ®Google Scholar
• Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239.
   PubMed Web of Science ®Google Scholar
• Gao J, Tian Z, Yang X. Break through: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. BST. 2020;14(1):72–3.
   Google Scholar
• https://hsgm.saglik.gov.tr/tr/covid19.
   Google Scholar
• Mehta V, Goel S, Kabarriti R, Cole D, Goldfinger M, Acuna-Villaorduna A, et al. Case fatality rate of cancer patients with COVID-19 in a New York hospital system. Cancer Discov. 2020. (published online May 1.). https://doi.org/10.1158/2159-8290.CD-20-0516.
   Google Scholar
• Kuderer NM, Choueiri TK, Shah DY, Rubinstein SM, Rivera DR, Shete S, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet 2020;395:P1907–18.
   Google Scholar
• Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan. Ann Oncol. 2020 Jul;31(7):894–901. Epub 2020 Mar 26.
   PubMed Web of Science ®Google Scholar
• Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature Aug 2020;584(7821):430–6. 2521-4. Epub 2020 Jul 8. PMID: 32640463.
   PubMed Web of Science ®Google Scholar
• Miyashita H, Mikami T, Chopra N, Yamada T, Chernyavsky S, Rizk D, et al. Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City. Ann Oncol. 2020;31(8):1088–9.
   PubMed Web of Science ®Google Scholar
• Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020 Mar 23.
   PubMed Web of Science ®Google Scholar
• Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al., the Northwell COVID-19 Research Consortium. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020 May 26;323(20):2052–9.
   PubMed Web of Science ®Google Scholar
• Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, et al., China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.
   PubMed Web of Science ®Google Scholar
• Garg S, Kim L, Whitaker M, O'Halloran A, Cummings C, Holstein R, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019—COVID-NET, 14 States, March 1–30, 2020. MMWR Morb Mortal Wkly Rep. 2020.
   Google Scholar
• Stokes EK, Zambrano LD, Anderson KN, Marder EP, Raz KM, El Burai Felix S, et al. Coronavirus disease 2019 case surveillance - United States, January 22-May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020 Jun 19; 69(24):759–65. PMID: 32555134; PMCID: PMC7302472.
   PubMed Web of Science ®Google Scholar
• Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020 Feb 7;323(11):1061–9.
   PubMed Web of Science ®Google Scholar
• Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. Clinical characteristics of Covid-19 in New York City. N Engl J Med. 2020;382(24):2372–4.
   PubMed Web of Science ®Google Scholar
• Indini A, Rijavec E, Ghidini M, Cattaneo M, Grossi F. Developing a risk assessments core for patients with cancer during the Coronavirus disease 2019 pandemic. Eur J Cancer 2020 Aug;135:47–50. Epub 2020 May 31.
   PubMed Web of Science ®Google Scholar
• Sağlık TC, Halk B, Genel SM. SARS-CoV-2 EnfeksiyonuRehberi-BilimKuruluÇalışması; 2020 [cited 2020 April 14]. Available from: https://covid19bilgi.saglik.gov.tr/depo/rehberler/COVID19_Rehberi.pdftype=fileCOVID19.
   Google Scholar
• Van Dam PA, Huizing M, Mestach G, Dierckxsens S, Tjalma W, Papadimitriou K, et al. High mortality of cancer patients in times of SARS-CoV-2: Do not generalize!. Eur J Cancer 2020;138:225–7. Oct
   PubMedGoogle Scholar